Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYLILLY ELI | 704.837 B CHF | 725 CHF | −0.68% | 25 | 1.32 | 120.36 | 6.02 CHF | +6.31% | 0.59% | Health Technology | Buy |
LLYELI LILLY AND CO | 704.837 B CHF | 740.871 CHF | +0.91% | 1 | 0.03 | 122.99 | 6.02 CHF | +6.31% | 0.59% | Health Technology | Buy |
NOVNOVO NORDISK A/S | 538.279 B CHF | 122.182 CHF | +0.44% | 246 | 0.67 | 47.14 | 2.59 CHF | +44.47% | 1.01% | Health Technology | Buy |
JNJJOHNSON & JOHNSON | 319.114 B CHF | 132.384 CHF | +0.85% | 40 | 1.24 | 21.14 | 6.26 CHF | +43.07% | 3.28% | Health Technology | Buy |
6MKMERCK & CO INC | 287.455 B CHF | 113.072 CHF | −1.14% | 2 | 0.04 | 139.53 | 0.81 CHF | −82.71% | 2.39% | Health Technology | Strong buy |
4ABABBVIE INC | 257.405 B CHF | 139.987 CHF | −8.92% | 150 | 0.98 | 46.20 | 3.03 CHF | −22.07% | 3.76% | Health Technology | Buy |
ZEGASTRAZENECA PLC | 217.529 B CHF | 137.453 CHF | −3.30% | 15 | 0.56 | 37.44 | 3.67 CHF | +28.81% | 1.87% | Health Technology | Buy |
ROROCHE I | 187.219 B CHF | 252.8 CHF | +1.04% | 159.334 K | 3.57 | 17.68 | 14.30 CHF | −11.70% | 3.80% | Health Technology | Neutral |
RHO5ROCHE HLDGS AG | 187.219 B CHF | 231.822 CHF | +1.58% | 2.04 K | 31.48 | 16.21 | 14.30 CHF | −11.70% | 4.16% | Health Technology | Neutral |
RHOROCHE HLDGS AG | 187.219 B CHF | 249.063 CHF | −0.68% | 100 | 1.30 | 17.42 | 14.30 CHF | −11.70% | 3.80% | Health Technology | Neutral |
ROGROCHE GS | 187.219 B CHF | 231.0 CHF | +1.18% | 2.382 M | 1.71 | 16.15 | 14.30 CHF | −11.70% | 4.16% | Health Technology | Neutral |
NOVNEENOVARTIS N 2. LINIE | 184.543 B CHF | 93.06 CHF | +1.67% | 250 K | 1.00 | 14.25 | 6.53 CHF | +110.97% | 3.54% | Health Technology | — |
NOTNOVARTIS AG | 184.543 B CHF | 92.619 CHF | +1.62% | 205 | 3.03 | 14.18 | 6.53 CHF | +110.97% | 3.54% | Health Technology | Neutral |
NOVNNOVARTIS N | 184.543 B CHF | 93.17 CHF | +2.13% | 10.828 M | 4.17 | 14.27 | 6.53 CHF | +110.97% | 3.54% | Health Technology | Neutral |
AMGAMGEN INC | 148.324 B CHF | 287.771 CHF | +1.79% | 1 | 0.06 | 45.62 | 6.31 CHF | −53.17% | 2.86% | Health Technology | Buy |
PFEPFIZER INC | 146.82 B CHF | 25.592 CHF | +0.77% | 165 | 0.38 | — | −0.05 CHF | −101.18% | 5.79% | Health Technology | Buy |
VX1VERTEX PHARMACEUTICALS INC | 106.226 B CHF | 406.482 CHF | +0.52% | 20 | 2.02 | 29.23 | 13.91 CHF | +21.00% | 0.00% | Health Technology | Buy |
RGOREGENERON PHARMACEUTICALS INC | 97.619 B CHF | 885.423 CHF | +1.09% | 10 | 0.94 | 28.99 | 30.54 CHF | −9.39% | 0.00% | Health Technology | Buy |
GS71GSK PLC | 82.924 B CHF | 20.386 CHF | +0.86% | 1 | 0.01 | 16.39 | 1.24 CHF | −68.16% | 3.34% | Health Technology | Buy |
BRMBRISTOL-MYRS SQUIB | 75.3 B CHF | 37.962 CHF | −6.49% | 100 | 0.50 | — | −2.80 CHF | −189.04% | 5.69% | Health Technology | Neutral |
ZOEZOETIS INC | 69.945 B CHF | 156.049 CHF | +7.33% | 25 | 1.02 | 33.34 | 4.68 CHF | +15.52% | 0.95% | Health Technology | Strong buy |
LO3LONZA GROUP AG | 36.131 B CHF | 486.702 CHF | +0.84% | 260 | 46.43 | 54.83 | 8.88 CHF | −77.54% | 0.82% | Health Technology | Strong buy |
LONNELONZA N 2. LINIE | 36.131 B CHF | 486.9 CHF | −0.55% | 4.2 K | 1.07 | 54.86 | 8.88 CHF | −77.54% | 0.82% | Health Technology | — |
LONNLONZA N | 36.131 B CHF | 486.4 CHF | −0.45% | 406.117 K | 2.08 | 54.80 | 8.88 CHF | −77.54% | 0.82% | Health Technology | Strong buy |
BAYNBAYER AG | 27.172 B CHF | 27.480 CHF | +1.17% | 20 | 0.03 | — | −3.09 CHF | −200.75% | 0.39% | Health Technology | Neutral |
UNCUCB | 23.836 B CHF | 128.001 CHF | +7.50% | 20 | 0.31 | 78.38 | 1.63 CHF | −71.10% | 0.74% | Health Technology | Buy |
GGALDGALDERMA GROUP N | 17.407 B CHF | 73.27 CHF | −0.30% | 152.413 K | 0.86 | — | — | — | 0.00% | Health Technology | Buy |
SDZSANDOZ GROUP N | 13.818 B CHF | 32.06 CHF | +1.04% | 2 M | 2.33 | — | — | — | 1.40% | Health Technology | Buy |
D8YSANDOZ GROUP AG | 13.818 B CHF | 32.252 CHF | +2.01% | 1.805 K | 21.49 | — | — | — | 1.40% | Health Technology | Buy |
BANBBACHEM HOLDING AG | 6.063 B CHF | 79.643 CHF | −11.05% | 198 | 0.92 | 53.36 | 1.49 CHF | −7.80% | 0.99% | Health Technology | Neutral |
BANBBACHEM N | 6.063 B CHF | 80.85 CHF | −1.82% | 121.636 K | 1.96 | 54.17 | 1.49 CHF | −7.80% | 0.99% | Health Technology | Neutral |
SFZNSIEGFRIED N | 3.859 B CHF | 899 CHF | +2.16% | 11.971 K | 2.36 | 34.28 | 26.22 CHF | +19.06% | 0.40% | Health Technology | Buy |
SQGSIEGFRIED HLDG AG | 3.859 B CHF | 897.472 CHF | +1.91% | 2 | 0.19 | 34.22 | 26.22 CHF | +19.06% | 0.40% | Health Technology | Buy |
EVTEVOTEC SE | 1.503 B CHF | 8.450 CHF | −9.48% | 1 K | 1.23 | — | −0.50 CHF | −182.96% | 0.00% | Health Technology | Strong buy |
41XARDELYX INC | 1.451 B CHF | 7.357 CHF | −9.92% | 500 | 0.33 | — | −0.26 CHF | +28.58% | 0.00% | Health Technology | Strong buy |
C43COSMO PHARMA N.V. | 1.192 B CHF | 73.409 CHF | +2.47% | 150 | 0.17 | 887.65 | 0.08 CHF | −93.91% | 1.45% | Health Technology | Strong buy |
COPNCOSMO PHARM N | 1.192 B CHF | 70.8 CHF | +0.43% | 26.123 K | 2.41 | 856.11 | 0.08 CHF | −93.91% | 1.45% | Health Technology | Strong buy |
5CVCUREVAC NV | 788.816 M CHF | 3.564 CHF | +5.29% | 370 | 0.25 | — | −1.19 CHF | +15.68% | 0.00% | Health Technology | Buy |
FYBFORMYCON AG | 766.078 M CHF | 43.735 CHF | −1.85% | 200 | 1.22 | 9.96 | 4.39 CHF | — | 0.00% | Health Technology | Strong buy |
BSLNBASILEA N | 525.789 M CHF | 43.70 CHF | +0.23% | 28.528 K | 1.14 | 82.73 | 0.53 CHF | — | 0.00% | Health Technology | Buy |
PK5BASILEA PHARMACEU | 525.789 M CHF | 43.770 CHF | +6.92% | 75 | 0.29 | 82.87 | 0.53 CHF | — | 0.00% | Health Technology | Buy |
19TIDORSIA LTD | 490.181 M CHF | 2.559 CHF | +13.43% | 500 | 0.06 | — | −0.59 CHF | +87.58% | 0.00% | Health Technology | Sell |
IDIAIDORSIA N | 490.181 M CHF | 2.594 CHF | +2.61% | 505.16 K | 0.89 | — | −0.59 CHF | +87.58% | 0.00% | Health Technology | Sell |
0ETESPERION THERAPEUT | 332.778 M CHF | 2.009 CHF | −7.63% | 2.5 K | — | — | −0.91 CHF | +70.90% | 0.00% | Health Technology | Buy |
ER4EMERGENT BIOSOLUTI | 270.027 M CHF | 4.346 CHF | +128.86% | 1.5 K | 5.43 | — | −9.94 CHF | −34.83% | 0.00% | Health Technology | Neutral |
NWRNNEWRON PHARMA N | 186.318 M CHF | 10.00 CHF | +2.99% | 72.653 K | 1.09 | — | −0.88 CHF | +2.62% | 0.00% | Health Technology | Strong buy |
SANNSANTHERA N | 86.594 M CHF | 9.87 CHF | −1.30% | 17.007 K | 1.08 | 1.97 | 5.01 CHF | — | 0.00% | Health Technology | Buy |
CURNCURATIS N | 30.253 M CHF | 6.90 CHF | −4.83% | 3.82 K | 0.51 | — | −170.60 CHF | −4277.01% | 0.00% | Health Technology | — |
RLFRELIEF THERAPEUTICS N | 15.456 M CHF | 1.265 CHF | −2.32% | 2.342 K | 0.31 | — | −8.42 CHF | −377.09% | 0.00% | Health Technology | — |
ADXNADDEX N | 13.2 M CHF | 0.0716 CHF | +4.99% | 28.821 K | 0.10 | — | −0.14 CHF | +71.60% | 0.00% | Health Technology | Strong sell |
SPEXSPEXIS N | 4.182 M CHF | 0.0618 CHF | −4.04% | 620.217 K | 5.21 | — | −0.34 CHF | +81.25% | 0.00% | Health Technology | — |